Growth and change of COVID-19 until 2030

The main players in the CRISPR technology market are Thermo Fisher Scientific, GenScript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine, Horizon Discovery Plc. , Integrated DNA Technologies, Inc.

New York, September 24, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the publication of the report “CRISPR Technology Global Market Report 2021: COVID-19 Growth And Change To 2030” – https://www.reportlinker.com / p06151664 / ? utm_source = GNW
(Danaher), Origene Technologies, Inc., Transposagenbio Biopharmaceuticals (Hera Biolabs), Intellia Therapeutics Inc. and GeneCopoeia Inc.

The global CRISPR technology market is expected to grow from $ 0.8 billion in 2020 to $ 0.95 billion in 2021 at a compound annual growth rate (CAGR) of 18.8%. The growth is primarily driven by businesses resuming operations and adjusting to the new normal while recovering from the impact of COVID-19, which previously led to restrictive containment measures involving social distancing, the remote work and closure of business activities which resulted in operational challenges. The market is expected to reach $ 2.22 billion in 2025 at a CAGR of 24%.

The CRISPR technology market includes sales of products and services of CRISPR technology which is gene editing technology that enables researchers to modify DNA sequences and alter gene function. Revenue generated by the market includes sales of products such as design tools, plasmids and vector, Cas9 and gRNA, libraries and delivery system products and services which include vector design and construction, screening and l cell line engineering.

These products and services are used in genome editing / genetic engineering, genetically modifying organisms, agricultural biotechnology and others which include the gRNA gene database / library, CRISPR plasmid, human stem cells and end-user engineering of cell lines. End users include pharmaceutical and biopharmaceutical companies, biotechnology companies, academic and research institutes, and contract research organizations.

The CRISPR Technology market covered in this report is segmented by Product Type into Design Tools, Plasmid and Vector, CAS9 and G-RNA, Delivery System Products. It is also segmented by application into Genome Editing / Genetic Engineering, Genetically Modified Organisms, Agricultural Biotechnology, Others and by End User into Industrial Biotechnology, Biological Research, Agricultural Research, Therapeutics and Drug Discovery.

The regions covered in this report are Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East & Africa.

Strict government regulations are expected to retard the growth of the CRISPR technology market during the period. conducted with gene editing and applications and products related to gene editing.

The Court of Justice of the European Union has ruled that it will treat genetically modified crops as genetically modified organisms, subject to strict regulation. In April 2019, the Australian government said that the Office of the Gene Technology Regulator (OGTR) would only regulate gene editing technologies that use a pattern or insert other genetic material into the cell.

According to a 2020 article, in India, in accordance with national guidelines for stem cell research, genome modification including gene editing by CRISPR-Cas9 technology from stem cells, germ stem cells or gametes and human embryos is limited only to in-vitro studies. Thus, strict government regulations pose a threat to the growth of the market.

In 2019, Cardea Bio Inc., a US-based biotech infrastructure company that manufactures biologically gated transistors (Cardean transistors) that use biocompatible graphene instead of silicon and replace observations of optical signals with a direct analysis of electrical molecular signals, merged with Nanosens Innovations, Inc. The merger aims to accelerate the development of the genomic sensor that combines Nanosens’ CRISPR-Chip technology with Cardea’s graphene biosensor infrastructure and is the premier research engine DNA to the world that runs on CRISPR-Chip technology. Nanosens will operate as a subsidiary of Cardea Bio. Nanosens Innovations, Inc. is a United States-based biotechnology company that develops CRISPR-Chip and FEB technologies.

The application of CRISPR technology as a diagnostic tool is expected to drive the market during the period. The Sherlock CRISPR SARS-CoV-2 Kit is the first diagnostic kit based on CRISPR technology for infectious diseases caused by COVID-19.

In May 2020, the FDA announced the emergency use authorization of Sherlock BioSciences Inc’s Sherlock CRISPR SARS-CoV-2 Kit, which is a CRISPR-based Specific High-sensitivity Enzymatic Reporter (SHERLOCK) diagnostic test. . This test helps to specifically target SARS-CoV-2 virus RNA or DNA sequences from samples or samples such as nasal swabs from the upper respiratory tract and fluid in the lungs from bronchoalveolar lavage samples.

This diagnostic kit has high specificity and sensitivity and does not provide false negative or positive results. Expanding the application of CRISPR technology for the diagnosis of infectious diseases will increase the demand for CRISPR technology products and services.

Several advances in CRISPR technology are in vogue in the market during the period. Technological advances will help reduce errors, limit unwanted effects, improve the precision of the tool, broaden its applications, develop gene therapies, etc.

In 2019, a study published in Springer Nature reported the development of an advanced new ultra-precise CRISPR tool that allows researchers to better control DNA changes. This tool appears to have the ability to deliver a wider variety of genetic modifications that could potentially open up. conditions that have challenged gene editors.

Additionally, in 2020, another study from Springer Nature said that researchers used enzyme engineering to increase the precision of the error-prone CRISPR-Cas9 system technique to precisely target DNA without introducing as many mutations. unwanted. Advances in CRISPR technology will translate into better tools capable of delivering better results.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom and United States.
Read the full report: https://www.reportlinker.com/p06151664/?utm_source=GNW

About Reportlinker
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

About Alma Ackerman

Check Also

What happens in the brain when it’s too hot?

Researchers have found that heat turns off the brain. Zebrafish experiments demonstrate how vulnerable freshwater …

Leave a Reply

Your email address will not be published.